These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6305671)

  • 21. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.
    Labenz J; Tillenburg B; Peitz U; Verdú E; Stolte M; Börsch G; Blum AL
    Gut; 1997 Jul; 41(1):33-6. PubMed ID: 9274468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine compared with cimetidine in the short-term healing of duodenal ulcer.
    Lee FI; Fielding JD; Costello FT
    Postgrad Med J; 1983 Feb; 59(688):88-92. PubMed ID: 6302650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ranitidine on the content of glyceroglucolipids in gastric secretion of patients with gastric and duodenal ulcer.
    Sarosiek J; Slomiany BL; Slomiany A; Gabryelewicz A
    Scand J Gastroenterol; 1984 Jul; 19(5):650-4. PubMed ID: 6089304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranitidine in the prevention of gastric and duodenal ulcer relapse.
    Alstead EM; Ryan FP; Holdsworth CD; Ashton MG; Moore M
    Gut; 1983 May; 24(5):418-20. PubMed ID: 6301956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology and clinical use of ranitidine.
    Konturek SJ
    Mt Sinai J Med; 1982; 49(5):370-82. PubMed ID: 6294510
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetic determination of ranitidine pharmacodynamics in pediatric ulcer disease.
    Blumer JL; Rothstein FC; Kaplan BS; Yamashita TS; Eshelman FN; Myers CM; Reed MD
    J Pediatr; 1985 Aug; 107(2):301-6. PubMed ID: 4020560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
    Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
    Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
    Giacosa A; Cheli R; Molinari F; Parodi MC
    Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ranitidine inhibition of gastric secretion stimulated by pentagastrin. Results in 30 cases of duodenal ulcer].
    Toulet J; Pagniez R; Viteau JM; Rousselet J; Bosc F; Vienne JL
    Ann Gastroenterol Hepatol (Paris); 1986; 22(1):9-14. PubMed ID: 3083759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.
    Helman CA; Tim LO
    Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.
    Kummer AF; Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger SA
    Gut; 1992 Feb; 33(2):175-8. PubMed ID: 1541412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
    van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranitidine in uncomplicated duodenal ulceration. A double-blind endoscopically controlled trial.
    Moshal MG; Spitaels JM; Khan F
    S Afr Med J; 1981 Sep; 60(10):393-4. PubMed ID: 6269234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease.
    Thomson AB; Mahachai V; Bailey RJ; Kirdeikis P; Zuk L; Marriage B; Simpson I; Jamali F
    J Gastroenterol Hepatol; 1996 Dec; 11(12):1171-6. PubMed ID: 9034938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of basal acid, chloride, and pepsin secretion in duodenal ulcer by graded doses of ranitidine and atropine with studies of pharmacokinetics of ranitidine.
    Hirschowitz BI; Danilewitz M; Molina E
    Gastroenterology; 1982 Jun; 82(6):1314-26. PubMed ID: 6279466
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
    Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
    Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF; Frazer NM; Keene ON; Smith JT
    Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ranitidine in the treatment of acute upper gastrointestinal haemorrhage--a comparative study. Preliminary report.
    Nowak A; Sadliński C; Górka Z; Nowakowska E; Rudzki J; Gibiński K
    Hepatogastroenterology; 1981 Oct; 28(5):267-9. PubMed ID: 6124495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranitidine bioavailability and kinetics in normal male subjects.
    Garg DC; Weidler DJ; Eshelman FN
    Clin Pharmacol Ther; 1983 Apr; 33(4):445-52. PubMed ID: 6299642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Sica DA; Comstock T; Harford A; Eshelman F
    Eur J Clin Pharmacol; 1987; 32(6):587-91. PubMed ID: 3653228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.